Intent to Sole Source - Olink Reagents
Closed Special Notice Posted
- Solicitation number
- NOI-CC-OLAO-26-006363
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Clinical Center issued a Notice of Intent on June 11, 2026 to sole-source Olink reagents to Olink Proteomics Inc., with a capability statement deadline of June 21, 2026 at 12:00 PM Eastern time. This is not a request for proposal. The sole-source justification rests on FAR 6.302-1 (only one responsible source): Olink Proteomics manufactures the Q100 Instrument and is the sole supplier of reagents compatible with it, as the instrument accepts only validated Olink reagents and no other vendor supplies compatible alternatives. Any responsible source that could fulfill the requirement may submit a capability statement by email to valerie.gregorio@nih.gov with subject line NOI-OLAO-CC-26-006363. All statements received by the closing date will be reviewed, though the Government retains sole discretion to award on a sole-source basis or compete the requirement based on responses received.
Notice text
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Olink Proteomics Inc.
Acquistion Description:
Olink Proteomics Inc. is the manufacturer of Q100 Instrument and the only company that sell reagents compatible with the Q100 Instrument. The Olink Q100 Instrument will only validated Olink reagents. No other vendor supplies reagents compatible with the Olink® Q100 Instrument.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-006363) by 12:00 PM eastern standard time on 06/21/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| Intent to Sole Source - Fertility Preservation Lab Services | National Institutes of Health | No set-aside | |
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Service agreement for the Nikon AXR-NSPARC confocal | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity